WolverHeme Happy Hour

A podcast by Bernard Marini, Anthony Perissinotti, et al.

31 Episodes

  1. Episode 10: ASH Recap Part 2 - Papa Heme + WolverHeme

    Published: 12/21/2022
  2. Episode 9: ASH Recap Part 1 - Dauno-Double Trouble

    Published: 12/14/2022
  3. Episode 8: Pulling the Goalie on FLT3 Inhibitor Use in AML - A Discussion with Dr. Dale Bixby

    Published: 11/23/2022
  4. Episode (3+)7: Straight Outta Roswell - OG AML Data

    Published: 10/7/2022
  5. Episode 6: Dr. StrangeDrug or: How I Learned to Stop Worrying and Love the Asparaginase

    Published: 7/21/2022
  6. Episode 5: IDH Inhibitors in AML: not so AGILE

    Published: 6/3/2022
  7. Episode 4: All Aboard the Oncology StewardSHIP

    Published: 5/27/2022
  8. Episode 3.2: Ranting About Rituximab in Acute Lymphoblastic Leukemia

    Published: 4/22/2022
  9. Episode 3.1: History of Acute Lymphoblastic Leukemia Treatment and Building the BFM Backbone

    Published: 4/22/2022
  10. Episode 2: We Don't Talk About Rylaze

    Published: 3/18/2022
  11. Episode 1: Surrogate Endpoints in AML

    Published: 3/11/2022

2 / 2

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.